Shah Capital Management Novavax Inc Transaction History
Shah Capital Management
- $252 Million
- Q4 2024
A detailed history of Shah Capital Management transactions in Novavax Inc stock. As of the latest transaction made, Shah Capital Management holds 11,148,846 shares of NVAX stock, worth $93.4 Million. This represents 35.54% of its overall portfolio holdings.
Number of Shares
11,148,846
Previous 9,815,541
13.58%
Holding current value
$93.4 Million
Previous $124 Million
27.7%
% of portfolio
35.54%
Previous 40.63%
Shares
11 transactions
Others Institutions Holding NVAX
# of Institutions
285Shares Held
93.8MCall Options Held
5.4MPut Options Held
8.76M-
Vanguard Group Inc Valley Forge, PA15.7MShares$132 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$99.3 Million0.0% of portfolio
-
State Street Corp Boston, MA7.7MShares$64.5 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.79MShares$48.5 Million0.04% of portfolio
-
Morgan Stanley New York, NY4.94MShares$41.4 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $655M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...